Nutrient-driven histone code determines exhausted CD8 + T cell fates

Exhausted T cells (TEX) in cancer and chronic viral infections undergo metabolic and epigenetic remodeling, impairing their protective capabilities. However, the impact of nutrient metabolism on epigenetic modifications that control TEX differentiation remains unclear. We showed that TEX cells shift...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Science (American Association for the Advancement of Science) 2024-12, p.eadj3020
Hauptverfasser: Ma, Shixin, Dahabieh, Michael S, Mann, Thomas H, Zhao, Steven, McDonald, Bryan, Song, Won-Suk, Chung, H Kay, Farsakoglu, Yagmur, Garcia-Rivera, Lizmarie, Hoffmann, Filipe Araujo, Xu, Shihao, Du, Victor Y, Chen, Dan, Furgiuele, Jesse, LaPorta, Michael, Jacobs, Emily, DeCamp, Lisa M, Oswald, Brandon M, Sheldon, Ryan D, Ellis, Abigail E, Liu, Longwei, He, Peixiang, Wang, Yingxiao, Jang, Cholsoon, Jones, Russell G, Kaech, Susan M
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Exhausted T cells (TEX) in cancer and chronic viral infections undergo metabolic and epigenetic remodeling, impairing their protective capabilities. However, the impact of nutrient metabolism on epigenetic modifications that control TEX differentiation remains unclear. We showed that TEX cells shifted from acetate to citrate metabolism by downregulating acetyl-CoA synthetase 2 (ACSS2) while maintaining ATP-citrate lyase (ACLY) activity. This metabolic switch increased citrate-dependent histone acetylation, mediated by histone acetyltransferase KAT2A-ACLY interactions, at TEX signature-genes while reducing acetate-dependent histone acetylation, dependent on p300-ACSS2 complexes, at effector and memory T cell genes. Nuclear ACSS2 overexpression or ACLY inhibition prevented TEX differentiation and enhanced tumor-specific T cell responses. These findings unveiled a nutrient-instructed histone code governing CD8 T cell differentiation, with implications for metabolic- and epigenetic-based T cell therapies.
ISSN:0036-8075
1095-9203
1095-9203
DOI:10.1126/science.adj3020